Dr. Martine A. Rothblatt Ph.D.United Therapeutics
Dr. Martine A. Rothblatt is a Chairman & Chief Executive Officer at United Therapeutics Corp., a Chief Executive Officer at Revivicor, Inc. and a President & Chief Executive Officer at Lung Biotechnology PBC. She is on the Board of Directors at United Therapeutics Europe Ltd., Beta Technologies, Inc. and The Kennedy Center Corporate Fund. Dr. Rothblatt was previously employed as a Chairman & Chief Executive Officer by SIRIUS Satellite Radio, Inc. She also served on the board at Synthetic Genomics, Inc. She received her graduate degree from the University of California, Los Angeles, an MBA from the University of California, Los Angeles and a doctorate degree from the University of London.
Year appointed: 1996